CN111374896A - Prebiotics and probiotic skin care product for treating acne and preparation method thereof - Google Patents

Prebiotics and probiotic skin care product for treating acne and preparation method thereof Download PDF

Info

Publication number
CN111374896A
CN111374896A CN201811625588.4A CN201811625588A CN111374896A CN 111374896 A CN111374896 A CN 111374896A CN 201811625588 A CN201811625588 A CN 201811625588A CN 111374896 A CN111374896 A CN 111374896A
Authority
CN
China
Prior art keywords
prebiotics
extract
probiotics
stirring
oligosaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811625588.4A
Other languages
Chinese (zh)
Inventor
王英
刘凤岩
杨晓蕾
李丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xi'an Zhenrui Biological Technology Co ltd
Original Assignee
Xi'an Zhenrui Biological Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xi'an Zhenrui Biological Technology Co ltd filed Critical Xi'an Zhenrui Biological Technology Co ltd
Priority to CN201811625588.4A priority Critical patent/CN111374896A/en
Publication of CN111374896A publication Critical patent/CN111374896A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin

Abstract

The invention discloses a prebiotics and probiotic skin care product for treating acne and a preparation method thereof, wherein the skin care product comprises the following components in percentage by mass: 1-4% of polyoxyethylene 100 stearate, 1-10% of prebiotics, 1-10% of probiotics, 1-5% of caprylic/capric triglyceride, 1-4% of stearic acid, 2-6% of glycerol, 0.01-0.2% of sodium hyaluronate, 0.1-2% of phytosterol, 0.1-2% of cetearyl alcohol, 0.1-3% of isononyl isononanoate, 1-10% of plant extract, 0.5-3% of hydroxyethyl cellulose, 0.1-0.5% of phenoxyethanol and the balance of water. The invention has simple formula, convenient use, good effect and no toxic or side effect.

Description

Prebiotics and probiotic skin care product for treating acne and preparation method thereof
Technical Field
The invention relates to the technical field of skin care products, in particular to a prebiotics and probiotic skin care product for treating acne and a preparation method thereof.
Background
The skin is the organ with the largest surface area of the human body and also the first defense line of the body for defending the invasion of harmful substances in the external environment, besides the physical barrier formed by keratinocytes, the skin can also secrete a plurality of substances such as antibacterial peptide, active oxygen, free fatty acid and the like, plays a role in directly killing pathogenic microorganisms invading the epidermis of the skin, and is an important component of the innate immunity of the human body. In addition, there have been long-term related studies that indicate that skin serves as a bioactive interface between the internal and external environments of the human body, and the surface of the skin inhabits a large number of microorganisms, including bacteria, fungi, and the like. These microorganisms form different niches on the skin surface, forming a complex ecosystem, the skin micro-ecology. Most microorganisms on the skin surface are harmless to the human body, and even some microorganisms are beneficial. The normal symbiotic flora of the skin can regulate and control inflammatory reaction after the skin is damaged and participate in local immune defense, and can inhibit the propagation of pathogenic microorganisms by directly secreting or inducing the generation of the antibacterial peptide of the body. However, when the balance relationship between the symbiotic bacteria on the skin surface is broken, the function of the skin is disturbed and diseases occur. Many studies have also demonstrated that the onset of a variety of inflammatory skin diseases such as acne, atopic dermatitis, and the delayed healing of chronic wounds are associated with disturbances in the skin flora.
Acne is commonly known as "whelk", "comedo" or "pimple", and is a chronic inflammatory skin disease of hair follicle sebaceous glands, which is mainly developed in adolescents and can also be seen in children and adults. The affected parts are mainly distributed on the parts with vigorous sebaceous gland secretion, such as the face, the neck, the chest and the back. The clinical manifestations are acne, papule, pustule, nodule and cyst. The disease is strongly related to the primary dysbiosis of the skin caused by the massive proliferation of propionibacterium acnes. Propionibacterium acnes mainly induces immune reactions and local inflammatory reactions of the body during the attack of acne. Acne treatment methods are various, and at present, medicaments such as vitamin A acids, antibiotics, antiandrogens and glucocorticoids are mainly used through oral administration or local external application. The methods have the advantages of long treatment period, large skin irritation caused by incomplete treatment, easy generation of drug resistance, easy recurrence of acne, large side effect and skin injury.
Probiotics are a class of active microorganisms that are beneficial in maintaining or enhancing a beneficial balance of microbial flora in the body. Typical probiotics are lactobacilli, including bifidobacteria, lactic acid bacteria, and the like. Prebiotics are non-digestible fermentable carbohydrates capable of selectively stimulating probiotics, and mainly comprise fructo-oligosaccharide, glucan, resistant starch and the like. Probiotics are commonly used as food and pharmaceuticals to maintain gastrointestinal microflora balance. In recent years, with intensive research on probiotics, it has been found that probiotics can be applied to the skin in addition to the skin, and thus have great potential in the aspects of protecting healthy skin, preventing and treating skin diseases, and the like. Studies have shown that an acidic skin environment can prevent bacterial colonization, while the probiotic microflora can provide a moist acidic barrier environment for the skin by fermenting metabolic acidic molecules (such as lactic acid), amino acids and other acidic substances. In addition, studies have shown that topical application to the skin, with probiotic, spore, and extracellular products as the major components, can prevent the growth of bacteria, fungi, viruses, and other compositions, effectively maintaining the normal function of healthy skin. Prebiotics can beneficially affect the host by selectively stimulating the growth and activity of one or a small number of probiotic bacteria to improve host health. Researches show that the prebiotics can help to maintain the natural protective barrier on the surface of the skin, increase the resistance of the skin to harmful bacteria, maintain the natural balance state of the skin and reduce the generation of skin problems.
With the rise of skin micro-ecology, a green ecological preparation is developed by utilizing the modern biotechnology to replace the traditional medicines such as antibiotics, hormones and the like, the steady state of healthy skin flora is recovered and maintained through probiotic intervention effectively, the aim of treating skin diseases is finally achieved, the micro-ecological balance of the skin is fundamentally adjusted and maintained, so that the skin problem is solved, and the preparation method becomes a new research direction in the field of skin care products/cosmetics.
In order to solve the defects of long treatment period, incomplete treatment, easy repetition, large side effect, easy formation of drug resistance, low total cure rate and the like of the existing facial acne treatment products, the invention provides a prebiotic and probiotic skin care product for treating facial acne. The skin care product containing the prebiotics and the probiotics provided by the invention takes the prebiotics and the probiotics as functional components, is supplemented with other effective components, has a remarkable effect of treating facial acne by the synergistic effect of the components, can improve the micro-ecology on the surface of the skin of a human body, and does not contain antibiotics and hormone components, and has mild effect, no skin irritation and high safety.
Disclosure of Invention
Aiming at the defects in the prior art, the prebiotics and probiotic bacteria skin care product provided by the invention takes the prebiotics and the probiotic bacteria as functional components, is supplemented with other effective components, has a synergistic effect among the components, can improve the micro-ecology on the surface of human skin, and has an obvious effect of treating facial acne.
In order to achieve the purpose, the invention provides the following technical scheme:
a prebiotic and probiotic skin care product for treating acne comprises the following components in percentage by mass: 1-4% of polyoxyethylene 100 stearate, 1-10% of prebiotics, 1-10% of probiotics, 1-5% of caprylic/capric triglyceride, 1-4% of stearic acid, 2-6% of glycerol, 0.01-0.2% of sodium hyaluronate, 0.1-2% of phytosterol, 0.1-2% of cetearyl alcohol, 0.1-3% of isononyl isononanoate, 1-10% of plant extract, 0.5-3% of hydroxyethyl cellulose, 0.1-0.5% of phenoxyethanol and the balance of water.
As a still further scheme of the invention: the prebiotics and probiotic skin care product for treating acne comprises the following components in percentage by mass: 2-3% of polyoxyethylene 100 stearate, 3-5% of prebiotics, 3-5% of probiotics, 2-4% of caprylic/capric triglyceride, 2-3% of stearic acid, 3-5% of glycerol, 0.01-0.1% of sodium hyaluronate, 0.5-1% of phytosterol, 0.5-1% of whale wax stearyl alcohol, 0.5-2% of isononyl isononanoate, 1-6% of plant extract, 0.5-3% of hydroxyethyl cellulose, 0.2-0.3% of phenoxyethanol and the balance of water.
The invention further adopts the scheme that the prebiotics are oat β glucan, fructo oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose, and the weight ratio of the prebiotics to the prebiotics is 2 (1-10).
As a still further scheme of the invention: the probiotics are bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri, and the mass ratio is 3: (1-10): (1-10): (1-10): (1-10): (1-10).
As a still further scheme of the invention: the plant extract is a horse chestnut extract, a wild soybean extract, a salvia miltiorrhiza root extract, a centella asiatica extract and a phellodendron amurense extract, and the weight ratio of the plant extract to the plant extract is 1: (1-10): (1-10): (1-10): (1-10).
As a still further scheme of the invention: the prebiotics and probiotic skin care product for treating acne comprises the following components in percentage by mass: 2% polyoxyethylene 100 stearate, 2.5% caprylic capric triglyceride, 3% stearic acid, 0.5% phytosterol, 1% cetearyl alcohol, 0.5% isononyl isononanoate, 5% prebiotics, 3% probiotics, 3% glycerol, 0.06% sodium hyaluronate, 1.5% hydroxyethyl cellulose, 5% plant extract, 0.25% phenoxyethanol, 72.69% water;
wherein the prebiotics comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose, and the mass ratio is 2: 3: 5: 1: 2: 1;
the probiotics comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 2: 4: 2: 2: 1;
the plant extract comprises a aesculus hippocastanum extract, a wild soybean extract, a salvia miltiorrhiza root extract, a centella asiatica extract and a phellodendron amurense extract, and the mass ratio of the extracts is 1: 2: 4: 3: 1.
as a still further scheme of the invention: the preparation method of the prebiotics and probiotic skin care product for treating acne comprises the following steps:
(1) heating and stirring polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate according to a proportion until the materials are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material A for later use;
(2) adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water according to a proportion, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use;
(3) mixing the plant extract and phenoxyethanol according to a proportion, and uniformly stirring to obtain a material C for later use;
(4) adding the material B into the material A, adding into an emulsifying pot, and homogenizing at 75-80 ℃ for 3-5 min;
(5) and (3) when the temperature of the materials in the emulsifying pot is reduced to below 45 ℃, adding the material C, uniformly stirring and then discharging.
The skin care product containing the prebiotics and the probiotics provided by the invention takes oat β glucan, fructo-oligosaccharide, α glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose as probiotics, takes bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri as probiotics, combines other effective components, can promote the proliferation of normal flora types of staphylococcus epidermidis, can inhibit the growth of potential pathogenic bacteria such as staphylococcus aureus, propionibacterium acnes and the like on the surface of the skin, and obviously regulates the flora balance in facial acne skin, wherein fatty acids such as lactic acid, acetic acid, butyric acid and the like generated by lactobacillus plantarum and lactobacillus reuteri can reduce the pH value of the skin, inhibit the growth and propagation of harmful bacteria, and have a protective effect on the skin.
The prebiotic and probiotic skin care product provided by the invention can contain plant extracts, including aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract, can inhibit the activity of 5 α reductase by inhibiting the conversion of testosterone into dihydrotestosterone, reduce the hyperfunction of sebaceous glands, balance sebum secretion, dredge pores, improve the keratinization of hair follicles, and improve the oily and acne-prone skin conditions.
In vitro experiments show that the composition can effectively promote the proliferation of normal flora types of staphylococcus epidermidis, and has obvious inhibiting effect on staphylococcus aureus and propionibacterium acnes which are acne pathogenic bacteria.
Clinical experiments show that the composition has a remarkable treatment effect on facial acne, the total effective rate is 96.2%, acne disappears after a subject continuously uses the composition, skin damage subsides, and damaged skin barriers are quickly and effectively repaired. And no side effects such as skin allergy, dryness, stabbing pain, inflammation and the like occur.
Drawings
FIG. 1 is a comparison graph of a patient with facial acne after one cycle of treatment with a composition of the present invention (comparison graph before and after treatment of a patient with facial acne).
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely below, and it should be apparent that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments.
Example 1:
the formula is as follows: polyoxyethylene 100 stearate 2%, prebiotics 3%, probiotics 5%, caprylic capric triglyceride 2%, stearic acid 2%, glycerin 5%, sodium hyaluronate 0.05%, phytosterol 1%, cetearyl alcohol 0.5%, isononyl isononanoate 2%, plant extract 6%, hydroxyethyl cellulose 1%, phenoxyethanol 0.3%, and water 70.15%.
The prebiotics of the embodiment comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 4: 3: 2: 1: 1.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 3: 5: 2: 1: 2.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 3: 5: 2: 1.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 2:
this example was formulated as in example 1, but the temperature and time of the preparation were varied. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring at constant temperature of 78 ℃ for 27min to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at constant temperature of 77 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 78 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 41 ℃, uniformly stirring and discharging.
Example 3:
the formula is as follows: polyoxyethylene 100 stearate 2%, prebiotics 5%, probiotics 3%, caprylic capric triglyceride 2.5%, stearic acid 3%, glycerin 3%, sodium hyaluronate 0.06%, phytosterol 0.5%, cetearyl alcohol 1%, isononyl isononanoate 0.5%, plant extract 5%, hydroxyethyl cellulose 1.5%, phenoxyethanol 0.25%, water 72.69%.
The prebiotics of the embodiment comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 3: 5: 1: 2: 1.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 2: 4: 2: 2: 1.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 2: 4: 3: 1.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 4:
this example was formulated as in example 3, but the temperature and time of the preparation were varied. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring at the constant temperature of 77 ℃ for 28min to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at the constant temperature of 78 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 78 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 43 ℃, uniformly stirring and then discharging.
Example 5:
the formula is as follows: polyoxyethylene 100 stearate 1.5%, prebiotics 4%, probiotics 4%, caprylic capric triglyceride 3%, stearic acid 2.5%, glycerin 4%, sodium hyaluronate 0.1%, phytosterol 1.5%, cetostearyl alcohol 0.8%, isononyl isononanoate 1%, plant extract 4%, hydroxyethyl cellulose 0.8%, phenoxyethanol 0.2%, water 72.6%.
The prebiotics of the embodiment comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 3: 3: 1: 2: 2.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 4: 3: 3: 1: 7.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 4: 3: 1: 3.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 6:
this example was formulated as in example 5, but the temperature and time of the preparation were varied. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 28min at constant temperature of 78 ℃ to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at the constant temperature of 78 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 77 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 42 ℃, uniformly stirring and discharging.
Example 7:
the formula is as follows: 1% of polyoxyethylene 100 stearate, 1% of prebiotics, 1% of probiotics, 1% of caprylic/capric triglyceride, 1% of stearic acid, 2% of glycerol, 0.01% of sodium hyaluronate, 0.1% of phytosterol, 0.1% of cetearyl alcohol, 0.1% of isononyl isononanoate, 1% of plant extract, 0.5% of hydroxyethyl cellulose, 0.1% of phenoxyethanol and 91.09% of water.
The prebiotics of the embodiment comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 1: 1: 1: 1: 1.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 1: 1: 1: 1: 1.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 1: 1: 1: 1.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 8:
this example was formulated identically to example 7, but with different temperatures and times in the preparation process. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 28min at constant temperature of 78 ℃ to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at the constant temperature of 78 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 77 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 42 ℃, uniformly stirring and discharging.
Example 9:
the formula is as follows: 4% of polyoxyethylene 100 stearate, 10% of prebiotics, 10% of probiotics, 5% of caprylic/capric triglyceride, 4% of stearic acid, 6% of glycerol, 0.2% of sodium hyaluronate, 2% of phytosterol, 2% of cetearyl alcohol, 3% of isononyl isononanoate, 10% of plant extract, 3% of hydroxyethyl cellulose, 0.5% of phenoxyethanol and 40.3% of water.
The prebiotics of the embodiment comprise β oat glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 10: 10: 10: 10: 10.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 10: 10: 10: 10: 10.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 10: 10: 10: 10.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 10:
this example was formulated as in example 9, but the temperature and time were varied during the preparation. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 28min at constant temperature of 78 ℃ to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at the constant temperature of 78 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 77 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 42 ℃, uniformly stirring and discharging.
Example 11:
the formula is as follows: polyoxyethylene 100 stearate 2%, prebiotics 5%, probiotics 5%, caprylic capric triglyceride 3%, stearic acid 2%, glycerin 4%, sodium hyaluronate 0.1%, phytosterol 1%, cetearyl alcohol 1%, isononyl isononanoate 1.5%, plant extract 6%, hydroxyethyl cellulose 1.7%, phenoxyethanol 0.3%, and water 67.4%.
The prebiotics of the embodiment comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 5: 5: 5: 5: 5.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 5: 5: 5: 5: 5.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 5: 5: 5: 5.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 12:
this example was formulated identically to example 11, but with a different temperature and time of preparation. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring at the constant temperature of 78 ℃ for 28min to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at the constant temperature of 78 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 77 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 42 ℃, uniformly stirring and discharging.
Example 13:
the formula is as follows: polyoxyethylene 100 stearate 2%, prebiotics 3%, probiotics 3%, caprylic capric triglyceride 2%, stearic acid 2%, glycerin 3%, sodium hyaluronate 0.01%, phytosterol 0.5%, cetostearyl alcohol 0.5%, isononyl isononanoate 0.5%, plant extract 1%, hydroxyethyl cellulose 0.5%, phenoxyethanol 0.2%, water 81.79%.
The prebiotics of the embodiment comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 1: 1: 1: 1: 1.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 1: 1: 1: 1: 1.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 1: 1: 1: 1.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 14:
this example was formulated identically to example 13, but with a different temperature and time of preparation. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring at the constant temperature of 78 ℃ for 28min to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at the constant temperature of 78 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 77 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 42 ℃, uniformly stirring and discharging.
Example 15:
the formula is as follows: 3% of polyoxyethylene 100 stearate, 5% of prebiotics, 5% of probiotics, 4% of caprylic/capric triglyceride, 3% of stearic acid, 5% of glycerol, 0.1% of sodium hyaluronate, 1% of phytosterol, 1% of cetearyl alcohol, 2% of isononyl isononanoate, 6% of plant extract, 3% of hydroxyethyl cellulose, 0.3% of phenoxyethanol and 61.6% of water.
The prebiotics of the embodiment comprise β oat glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 10: 10: 10: 10: 10.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 10: 10: 10: 10: 10.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 10: 10: 10: 10.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 16:
this example was formulated identically to example 15, but with different temperatures and times in the preparation process. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring at the constant temperature of 78 ℃ for 28min to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at the constant temperature of 78 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 77 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 42 ℃, uniformly stirring and discharging.
Example 17:
the formula is as follows: polyoxyethylene 100 stearate 2.5%, prebiotics 3.5%, probiotics 3.5%, caprylic capric triglyceride 3%, stearic acid 2.5%, glycerin 3.5%, sodium hyaluronate 0.05%, phytosterol 0.7%, cetearyl alcohol 0.8%, isononyl isononanoate 1.2%, plant extract 3.5%, hydroxyethyl cellulose 1.8%, phenoxyethanol 0.25%, and water 73.2%.
The prebiotics of the embodiment comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose in a mass ratio of 2: 5: 5: 5: 5: 5.
The probiotics of the embodiment comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri in a mass ratio of 3: 5: 5: 5: 5: 5.
the plant extracts of the embodiment comprise aesculus hippocastanum extract, wild soybean extract, salvia miltiorrhiza root extract, centella asiatica extract and phellodendron amurense extract according to the mass ratio of 1: 5: 5: 5: 5.
the preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring for 25-30 min at constant temperature of 75-80 ℃ to obtain a material A for later use. And adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. And adding the material B into the material A at the temperature of 75-80 ℃, and adding into an emulsifying pot for homogenizing for 3-5 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 40 ℃, uniformly stirring and then discharging.
Example 18:
this example was formulated identically to example 17, but with different temperatures and times. The preparation method comprises the following steps: weighing all the raw materials according to mass percentage, taking polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetearyl alcohol and isononyl isononanoate, heating and stirring until the raw materials are completely dissolved, and stirring at the constant temperature of 78 ℃ for 28min to obtain a material A for later use. Adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water, heating and stirring until completely dissolved, and stirring at the constant temperature of 78 ℃ for 27min to obtain a material B for later use. Mixing the plant extract and phenoxyethanol, and stirring to obtain material C. Adding the material B into the material A at 77 ℃, and adding into an emulsifying pot for homogenizing for 4 min. And (3) adding the material C when the temperature of the material in the emulsifying pot is reduced to 42 ℃, uniformly stirring and discharging.
In vitro experiments
The compositions of examples 1-18 were applied to skin microorganisms cultured in vitro and their regulatory effects on skin microorganisms were verified.
The test method is as follows:
(1) respectively inoculating Staphylococcus epidermidis (ATCC49134 standard strain) and Staphylococcus aureus (ATCC6538 standard strain) to YPDA liquid culture medium, and inoculating Propionibacterium acnes (ATCC6919 standard strain) to GAM broth culture medium.
(2) 20mL of each culture broth, 19 aliquots of each culture broth, were added with 0.2mL of the composition of examples 1-18 and 0.2mL of deionized water (control). Then putting staphylococcus epidermidis and staphylococcus aureus in a 37 ℃ incubator, culturing in an aerobic environment for 24 hours, putting propionibacterium acnes in the 37 ℃ incubator, and culturing in an anaerobic environment for 48 hours.
(3) The number of each bacterium in the culture solution before and after the culture was measured by the dilution plate method. The measurement results are shown in table 1.
TABLE 1 comparison of skin microbial counts before and after incubation (cfu/ml)
Figure BDA0001927913390000211
The experimental results prove that the composition can effectively promote the increment of the normal flora type of the staphylococcus epidermidis, and has obvious inhibiting effect on acne pathogenic bacteria staphylococcus aureus and propionibacterium acnes.
Clinical trial
The facial acne treatment comprises 80 facial acne patients, wherein 23 men and 57 women are in the group, the person with the largest age is 38 years old, the person with the smallest age is 16 years old, the average age is 21.8 years old, and all cases meet the acne diagnosis standard in the traditional Chinese medicine disease diagnosis curative effect standard (2012). During the test period, the patient cleans the face every morning and evening and then applies the composition, stops using other cosmetics and medicines, and keeps the light diet and regular work and rest, and the test period is 4 weeks. Recording the number, skin lesion degree and red and swollen conditions of facial acnes of the testee before and after the test; and the skin condition of each group of subjects was observed and the post-use experience of the subjects was revisited.
After 4 weeks of trial, most of 80 patients (56 patients) had acne disappeared, skin lesions resolved, and subjective symptoms disappeared; acne is reduced for 21 people, subjective symptoms are obviously relieved, and skin lesions are faded by more than 30 percent; 3 the symptoms of the people are not improved; the total cure rate is 70 percent, and the effective rate is 96.2 percent. In all cases, other adverse reactions such as skin allergy, dryness, pricking pain, inflammation and the like do not occur in the treatment process.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and equivalent alternatives or modifications according to the technical solution and the inventive concept of the present invention should be covered by the scope of the present invention.

Claims (7)

1. A prebiotics and probiotic skin care product for treating acne is characterized by comprising the following components in percentage by mass: 1-4% of polyoxyethylene 100 stearate, 1-10% of prebiotics, 1-10% of probiotics, 1-5% of caprylic/capric triglyceride, 1-4% of stearic acid, 2-6% of glycerol, 0.01-0.2% of sodium hyaluronate, 0.1-2% of phytosterol, 0.1-2% of cetearyl alcohol, 0.1-3% of isononyl isononanoate, 1-10% of plant extract, 0.5-3% of hydroxyethyl cellulose, 0.1-0.5% of phenoxyethanol and the balance of water.
2. The prebiotic and probiotic skin care product for the treatment of acne according to claim 1 comprising the following components in mass percent: 2-3% of polyoxyethylene 100 stearate, 3-5% of prebiotics, 3-5% of probiotics, 2-4% of caprylic/capric triglyceride, 2-3% of stearic acid, 3-5% of glycerol, 0.01-0.1% of sodium hyaluronate, 0.5-1% of phytosterol, 0.5-1% of cetearyl alcohol, 0.5-2% of isononyl isononanoate, 1-6% of plant extract, 0.5-3% of hydroxyethyl cellulose, 0.2-0.3% of phenoxyethanol and the balance of water.
3. The skin care product of prebiotics and probiotics for treating acne according to any one of claims 1-2, wherein the prebiotics are oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose, and the weight ratio is 2 (1-10).
4. The prebiotic and probiotic skin care product for the treatment of acne according to claims 1-2 wherein the probiotic is bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae, lactobacillus reuteri in a mass ratio of 3: (1-10): (1-10): (1-10): (1-10): (1-10).
5. The prebiotic and probiotic skin care product for the treatment of acne according to any of claims 1 to 2, characterized in that said plant extract is a horse chestnut extract, a wild soybean extract, a red sage root extract, a centella asiatica extract, a phellodendron amurense extract, in a weight ratio of 1: (1-10): (1-10): (1-10): (1-10).
6. The prebiotic and probiotic skin care product for the treatment of acne as defined in any of claims 1 to 2, comprising the following components in mass percent: 2% polyoxyethylene 100 stearate, 2.5% caprylic capric triglyceride, 3% stearic acid, 0.5% phytosterol, 1% cetearyl alcohol, 0.5% isononyl isononanoate, 5% prebiotics, 3% probiotics, 3% glycerol, 0.06% sodium hyaluronate, 1.5% hydroxyethyl cellulose, 5% plant extract, 0.25% phenoxyethanol, 72.69% water;
wherein the prebiotics comprise oat β glucan, fructo-oligosaccharide, α -glucan oligosaccharide, inulin, galacto-oligosaccharide and trehalose, and the mass ratio is 2: 3: 5: 1: 2: 1;
the probiotics comprise bifidobacterium longum, lactobacillus rhamnosus, streptococcus thermophilus, lactobacillus plantarum, saccharomyces cerevisiae and lactobacillus reuteri, and the mass ratio is 3: 2: 4: 2: 2: 1;
the plant extract comprises a aesculus hippocastanum extract, a wild soybean extract, a salvia miltiorrhiza root extract, a centella asiatica extract and a phellodendron amurense extract, and the mass ratio of the extracts is 1: 2: 4: 3: 1.
7. the method for preparing prebiotic and probiotic skin care product for the treatment of acne as defined in claim 1, comprising the steps of:
(1) heating and stirring polyoxyethylene 100 stearate, caprylic capric triglyceride, stearic acid, phytosterol, cetostearyl alcohol and isononyl isononanoate according to a proportion until the materials are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material A for later use;
(2) adding prebiotics, probiotics, glycerol, sodium hyaluronate and hydroxyethyl cellulose into water according to a proportion, heating and stirring until the prebiotics, the probiotics, the glycerol, the sodium hyaluronate and the hydroxyethyl cellulose are completely dissolved, and stirring for 25-30 min at a constant temperature of 75-80 ℃ to obtain a material B for later use;
(3) mixing the plant extract and phenoxyethanol according to a proportion, and uniformly stirring to obtain a material C for later use;
(4) adding the material B into the material A, adding into an emulsifying pot, and homogenizing at 75-80 ℃ for 3-5 min;
(5) and (3) when the temperature of the materials in the emulsifying pot is reduced to below 45 ℃, adding the material C, uniformly stirring and then discharging.
CN201811625588.4A 2018-12-28 2018-12-28 Prebiotics and probiotic skin care product for treating acne and preparation method thereof Pending CN111374896A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811625588.4A CN111374896A (en) 2018-12-28 2018-12-28 Prebiotics and probiotic skin care product for treating acne and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811625588.4A CN111374896A (en) 2018-12-28 2018-12-28 Prebiotics and probiotic skin care product for treating acne and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111374896A true CN111374896A (en) 2020-07-07

Family

ID=71217966

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811625588.4A Pending CN111374896A (en) 2018-12-28 2018-12-28 Prebiotics and probiotic skin care product for treating acne and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111374896A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111568846A (en) * 2020-07-08 2020-08-25 江苏雪豹日化有限公司 Anti-acne preparation
EP3973971A1 (en) * 2020-09-28 2022-03-30 Medice Arzneimittel Pütter GmbH & Co. KG Pharmaceutical compositions comprising a probiotic
CN114869840A (en) * 2022-06-08 2022-08-09 康柏利科技(苏州)有限公司 Prebiotics face cream and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110182861A1 (en) * 2008-07-29 2011-07-28 Isabelle Castiel Cosmetic use of microorganisms for the treatment of oily skin
PH22017000146U1 (en) * 2017-04-03 2017-05-05 Arturo C Ludan Probiotic skin barrier formulation
CN107412045A (en) * 2017-05-19 2017-12-01 广州蜜妆生物科技有限公司 A kind of prebiotics is good for skin facial mask
CN108670877A (en) * 2018-06-21 2018-10-19 佛山市三水区嘉华化学研究院(普通合伙) A kind of antibacterial anti-inflammatory acne cream and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110182861A1 (en) * 2008-07-29 2011-07-28 Isabelle Castiel Cosmetic use of microorganisms for the treatment of oily skin
PH22017000146U1 (en) * 2017-04-03 2017-05-05 Arturo C Ludan Probiotic skin barrier formulation
CN107412045A (en) * 2017-05-19 2017-12-01 广州蜜妆生物科技有限公司 A kind of prebiotics is good for skin facial mask
CN108670877A (en) * 2018-06-21 2018-10-19 佛山市三水区嘉华化学研究院(普通合伙) A kind of antibacterial anti-inflammatory acne cream and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
广州市恒束生物科技有限公司: "恒雪倩痘清灵祛痘益肤霜,备案编号:粤G妆网备字2016072623", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=201708281518193PN0H&NID=201708281518193PN0H》 *
王建新等: "《化妆品植物原料大全》", 30 June 2012, 中国纺织出版社 *
金青哲: "《功能性脂质》", 31 August 2013, 中国轻工业出版社 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111568846A (en) * 2020-07-08 2020-08-25 江苏雪豹日化有限公司 Anti-acne preparation
EP3973971A1 (en) * 2020-09-28 2022-03-30 Medice Arzneimittel Pütter GmbH & Co. KG Pharmaceutical compositions comprising a probiotic
CN114869840A (en) * 2022-06-08 2022-08-09 康柏利科技(苏州)有限公司 Prebiotics face cream and preparation method thereof

Similar Documents

Publication Publication Date Title
Sinha et al. The skin microbiome and the gut-skin axis
CN106794202B (en) Improve the composition of human skin health and its prepares the purposes in product
US20220296662A1 (en) Compositions and methods for promoting a healthy microbial flora in a mammal
KR101492003B1 (en) Probiotics of Lactobacillus plantarum HY7714 for skin wrinkle inhibitory and moisurizing effects and use of thereof as skin anti-wrinkle or moisturizing products
US20090035294A1 (en) Lipopolysaccharide fractions of vitreoscilla filiformis useful for stimulating the synthesis of anti-microbial peptides of the skin
CN110075046B (en) Composition capable of removing acne and trace
JP2014047212A (en) Method of use of lactobacillus-plantarum cmu995 strain
CN111374896A (en) Prebiotics and probiotic skin care product for treating acne and preparation method thereof
KR20190053216A (en) New cosmetic and / or functional food or dermatological use of yeast extract
CA3142566A1 (en) Compositions comprising a bacterial strain lactobacillus paracasei and hyaluronic acid and the use thereof for the treatment of the skin
CN112553117B (en) Lactobacillus reuteri capable of inhibiting skin stratum corneum thickening and application thereof
KR101975671B1 (en) Composition comprising the milk-cream fermentation product of lactic acid bacteria for preventing and improving atopic dermatitis
CN111632019A (en) Silk fibroin skin beautifying gel and preparation method thereof
CN108042456B (en) Preparation method and application of dendrobium officinale fermentation product
CN111568846A (en) Anti-acne preparation
WO2005030230A1 (en) Compositions and methods for treatment or prevention of psoriasis and related disorders
US20220339094A1 (en) Novel skin care composition
KR101969757B1 (en) Composition comprising fermented extracts for acne treatment
TW202202156A (en) Topical composition and its use for preparation of composition for improving skin disease and dermatitis
CN112773733A (en) Acne-removing composition and preparation method of emulsion thereof
JP2022543755A (en) Composition for skin condition improvement
CN116077415A (en) Ternary probiotic factor composition for regulating skin microecological balance
CN115414308A (en) Acne removing composition as well as preparation method and application thereof
CN111743826A (en) Freckle-removing, wrinkle-resisting and moisturizing emulsion
KR20060096851A (en) Lactobacillus plantarum which prevent and/or cure allergic diseases

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200707